Investors in Gilead Sciences can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Analysts expect a dividend of 2,29 USD per share. Gilead Sciences's dividend yield thus equals 3,27 percent. The average dividend yield of the biotech companies is a limited 0,5 percent.
Next Monday Gilead Sciences will publish its past quarters results. For this year Gilead Sciences's revenue will be around 21,82 billion USD. This is according to the average of the analysts' estimates. This is hugely lower than 2017's revenue of 26,11 billion USD.
The analysts expect for 2018 a net profit of 9,08 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 6,92 USD. The price-earnings-ratio equals 10,12.
Gilead Sciences's market capitalization is based on the number of outstanding shares around 91,5 billion USD. The Gilead Sciences stock was the past 12 months quite volatile. Since last February the stock is 13 percent lower. This year the stock price moved between 60 and 85 dollar. Since 2008 the stock price is almost 176 percent higher.On Thursday the stock closed at 70,01 USD.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.